Back at Pivot Park: Vivenics
Vivenics provides consultancy and software services for data management and data integrity.
Read more
Results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib
AstraZeneca and Acerta Pharma announce results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib.
Read more
NTRC’s Oncolines™ profiling is cover story in December issue of Molecular Cancer Therapeutics
An analysis by NTRC of 122 anti-cancer agents is cover story of Molecular Cancer Therapeutics.
Read more
PRIO Pharma launched at BIO Europe
PRIO pharma enables drug development innovations by co-creation.
Read more
New at Pivot Park: Mr. Pepper
“We are the Mr. Pepper company, the first independent distributor of social robotics solutions in the Netherlands.”
Read more
Dutch scientists honoured for Immuno Oncology Drug Development
Dutch scientists Hans van Eenennaam and John Dulos were part of the team that discovered KEYTRUDA.
Read more
Review – Topsector Cross-over Event
On the first of November the Topsector cross-over Event took place at Pivot Park.
Read more
Synaffix Enters into a Commercial License Agreement with ADC Therapeutics
Synaffix BV announced today it has entered into a Commercial License Agreement with ADC Therapeutics for its proprietary GlycoConnect™ and HydraSpace™ site-specific antibody-drug conjugate technologies.
Read more